Highly conserved amino-acid sequence between murine STAT3 and a revised human STAT3 sequence

被引:8
|
作者
Della Pietra, L [1 ]
Bressan, A [1 ]
Pezzotti, AR [1 ]
Serlupi-Crescenzi, O [1 ]
机构
[1] Ist Ricerca Cesare Serono, Drug Discovery Dept, I-00040 Ardea, Rome, Italy
关键词
APRF; polymerase chain reaction; messenger RNA; base sequence; amino-acid sequence homology;
D O I
10.1016/S0378-1119(98)00185-1
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Signal transducer and activator of transcription 3 (STAT3) is an important mediator of cytokine signaling, whose cDNA and protein sequences have been fully characterized. We sequenced the whole human STAT3 cDNA isolated from HepG2 cells. The new sequence determined contains 43 nucleotide changes overall, corresponding to six modifications at the amino-acid level. The revised amino-acid sequence of human STAT3 is now completely identical to the mouse sequence, except for a single amino-acid change at position 760. Thus STAT3 now results as one of the most evolutionarily conserved among known proteins. By using specific RT-PCR we could discriminate between the original sequence and the new variant. Amplification of regions within the src-homology domain 2 (SH2) of STAT3, from the RNAs of 11 different tissues or cells, revealed only the expression of the new SH2 variant. Besides, only this SH2 variant was amplified from human genomic DNA. We conclude that the new sequence we have determined in this study represents a revised sequence of hSTAT3 or, less likely, a new predominant allele. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:119 / 124
页数:6
相关论文
共 50 条
  • [1] Functional differences between Stat3 alpha and Stat3 beta
    Schaefer, TS
    Sanders, LK
    Park, OK
    Nathans, D
    MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (09) : 5307 - 5316
  • [2] STAT3 inhibition in prostate and pancreatic cancer lines by STAT3 binding sequence oligonucleotides:: differential activity between 5′ and 3′ ends
    Lewis, H. Dan
    Winter, Ashley
    Murphy, Thomas F.
    Tripathi, Snehlata
    Pandey, Virendra N.
    Barton, Beverly E.
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (06) : 1543 - 1550
  • [3] Targeting the STAT3 pathway with STAT3 degraders
    Wang, Zhijie
    Liao, Xiaotong
    He, Haiqi
    Guo, Xia
    Chen, Jianjun
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2024, 45 (09) : 811 - 823
  • [4] Novel STAT3 inhibitors targeting the STAT3 dimerization
    Hua, Yaping
    Azeem, Waqas
    Oyan, Anne Margrete
    Kalland, Karl-Henning
    CANCER RESEARCH, 2022, 82 (12)
  • [5] Eriocalyxin B Inhibits STAT3 Signaling by Covalently Targeting STAT3 and Blocking Phosphorylation and Activation of STAT3
    Yu, Xiaokui
    He, Li
    Cao, Peng
    Yu, Qiang
    PLOS ONE, 2015, 10 (05):
  • [6] Novel STAT3 Inhibitors Targeting STAT3 Dimerization by Binding to the STAT3 SH2 Domain
    Hua, Yaping
    Yuan, Xing
    Shen, Yun-heng
    Wang, Jinxin
    Azeem, Waqas
    Yang, Shuo
    Gade, Alexandra
    Lellahi, Seyed Mohammad
    oyan, Anne Margrete
    Ke, Xisong
    Zhang, Wei-dong
    Kalland, Karl-Henning
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [7] Identification and characterization of cis elements in the STAT3 gene regulating STAT3α and STAT3β messenger RNA splicing
    Shao, H
    Quintero, AJ
    Tweardy, DJ
    BLOOD, 2001, 98 (13) : 3853 - 3856
  • [8] Systemic evaluation of total Stat3 and Stat3 tyrosine phosphorylation in normal human tissues
    Chen, Chun-Liang
    Hsieh, Fu-Chuan
    Lin, Jiayuh
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2006, 80 (03) : 295 - 305
  • [9] Molecular interactions between STAT3 and protein inhibitor of activated STAT3, and androgen receptor
    Yamamoto, T
    Sato, N
    Sekine, Y
    Yumioka, T
    Imoto, S
    Junicho, A
    Fuse, H
    Matsuda, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 306 (02) : 610 - 615
  • [10] Activation of STAT3 in human meningiomas
    Wang, H
    Wang, H
    Ribalta, T
    Zhang, W
    Fuller, GN
    LABORATORY INVESTIGATION, 2003, 83 (01) : 293A - 293A